Navigation Links
Test for Calcium Buildup May Spot Heart Attack, Stroke Risk
Date:8/19/2011

THURSDAY, Aug. 18 (HealthDay News) -- A calcium test performed with the assistance of a CT scanner seems to provide insight into the likelihood that certain patients at moderate risk of heart problems will have a heart attack or stroke, researchers say.

The test to detect coronary calcium can help physicians determine whether the patients should take cholesterol-lowering drugs to reduce their cardiovascular risks, the study authors explained.

At issue are people who fall into the middle area between those who are at high risk of heart problems due to factors like high blood pressure and those who are at low risk. People in the so-called "gray zone" may have risk factors, such as being overweight or having high blood sugar levels, but they aren't considered in great danger.

The question is: Should those in the middle range of risk -- an estimated 6 million people in the United States -- be prescribed the anticholesterol drugs known as statins, which often work well but have side effects?

The study, published in the Aug. 19 issue of The Lancet, sought to determine whether a test of calcium in the arteries is more helpful at estimating risk than a blood test that examines levels of C-reactive protein.

The researchers tracked 2,083 people for six years. They found that 13 percent of those with the highest levels of calcium in their arteries had a heart attack or stroke during that time period. But just 2 percent of those with high levels of C-reactive protein -- and no calcium buildup -- had a heart attack or stroke.

Not everyone needs a calcium test, said lead study author Dr. Michael J. Blaha, a cardiology fellow at the Johns Hopkins University School of Medicine. However, he stated in a Hopkins news release, "we believe looking for calcification in coronary vessels in certain patients makes sense in order to predict who may benefit from statin therapy, because the test gets right to the heart of the disease we want to treat."

"Our data support recent American Heart Association guidelines, which say it is reasonable to order a coronary calcium scan for adults who are considered to be at intermediate risk of a heart attack over the next 10 years. A high coronary calcium score would indicate that statin therapy would likely be a useful strategy to lower that person's cardiovascular risk," study co-investigator Dr. Roger Blumenthal, director of the Ciccarone Center for the Prevention of Heart Disease at Johns Hopkins University, said in the news release.

Commenting on the study, cardiologist Dr. Vijay Nambi, an assistant professor at Baylor College of Medicine, said that most insurance companies don't cover the calcium tests, which cost in the range of $200-$400. "Sometimes people have to pay for it out of pocket," said Nambi, who thinks it's a useful test. "It helps physicians in a lot of respects."

Test results can also help patients make decisions when they're worried about taking anticholesterol drugs, Nambi added.

More information

For more about heart disease, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Johns Hopkins Medicine, news release, Aug. 18, 2011; Vijay Nambi, M.D., assistant professor, Baylor College of Medicine, Houston


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vitamin D, Calcium Combo May Halve Melanoma Risk in Some Women
2. With Calcium, More May Not Be Better
3. Americans May Not Consume Enough Calcium: Study
4. Women Taking Calcium Supplements May Risk Heart Health, Researchers Say
5. IOF statement on new IOM dietary reference intakes for calcium and vitamin D
6. Vitamin D and calcium -- updated dietary reference intakes from IOM
7. Calcium Supplements Linked to Boost in Heart Attack Risk
8. Calcium, Vitamin D Supplements OK for Arteries
9. Calcium supplements: too much of a good thing?
10. Calcium in early life may prevent obesity later
11. Calcium Scan Improves Heart Risk Prediction
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Test for Calcium Buildup May Spot Heart Attack, Stroke Risk
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on ... later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his ... the hospital’s 30th heart transplant recipient. , “He was playing at home, when we ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... AlignLife clinics nationwide ... Many children are not fortunate enough to receive bountiful gifts wrapped tightly under a ... can bring to the children of the world. , In exchange for generous donations, ...
(Date:12/7/2016)... OR (PRWEB) , ... December 07, 2016 , ... Sharon ... Water, Global Climate Change and Your Health on Voice of America, declared on her ... to call attention to the fact that when these bullies attack leaders in corporate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Research and Markets has announced the addition of the ... to 2021" report to their offering. ... , , The immunohistochemistry (IHC) ... a CAGR of 7.3% during the forecast period of 2016 to 2021. ... rapidly increasing geriatric population across the globe are the primary driving the ...
(Date:12/7/2016)... 7, 2016  Palatin Technologies, Inc. ("Palatin") (NYSE ... a previously disclosed underwritten public offering of units ... as sole book-running manager, Roth Capital Partners acted ... as co-manager for the offering. "This ... net proceeds, allowing us to continue advancing bremelanotide ...
(Date:12/7/2016)... , Dec. 7, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Janus Kinase 3 (JAK3) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
Breaking Medicine Technology: